Stay updated on NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial

Sign up to get notified when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The record history now shows a new release entry Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a minor site update to ClinicalTrials.gov rather than changes to trial data.
    Difference
    0.1%
    Check dated 2026-05-15T05:52:56.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page footer’s revision/version indicator was updated from 3.5.2 to 3.5.3 for the ClinicalTrials.gov site interface.
    Difference
    0.1%
    Check dated 2026-04-24T05:53:53.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added and revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:20:59.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The Record History shows the addition of revision v3.5.0 and the removal of revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:53:38.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.3) was added to the history log, replacing the previous revision (v3.4.2). This reflects a metadata update to the page without changes to core study data.
    Difference
    0.1%
    Check dated 2026-03-11T20:00:41.000Z thumbnail image
  9. Check
    111 days ago
    Change Detected
    Summary
    Record history shows a new Revision: v3.4.2 was added and the prior funding-notice revision (v3.4.1) was removed. This reflects maintenance/versioning rather than substantive study content.
    Difference
    0.7%
    Check dated 2026-02-11T10:20:31.000Z thumbnail image

Stay in the know with updates to NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.